Glenmark Recalls Estradiol Vaginal Inserts Due to Defective Plunger
Glenmark Pharmaceuticals is recalling Estradiol Vaginal Inserts because the plunger delivery system is not functioning properly.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the defect is a mechanical failure of the delivery system rather than a direct toxicological hazard or reported injury.
Plain-English summary
Glenmark Pharmaceuticals Inc. is recalling Estradiol Vaginal Inserts USP 10 mcg, packaged in boxes of 8. The recall affects 31,656 boxes distributed nationwide in the United States. The specific lot number is 20180516, with an expiration date of 4/30/2020.
The recall was initiated because the plunger in the delivery system is not functioning properly. This defect may prevent the vaginal insert from being administered correctly.
Consumers with this product should stop using it and contact their healthcare provider or pharmacist for guidance on how to dispose of the product or obtain a replacement.
The recalled product
- Product
- ESTRADIOL VAGINAL INSERTS (ESTRADIOL)
- Brand
- ESTRADIOL VAGINAL INSERTS
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Drug
- Affected units
- 31,656
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 20180516
- Exp 4/30/2020
UPCs (2)
- 0368462711880
- 0368462711712
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ESTRADIOL VAGINAL INSERTS
- ModerateGlenmark Recalls Estradiol Vaginal Inserts Due to Applicator Defect
FDA (Drugs) · 2019-11-06
- ModerateGlenmark Recalls Estradiol Vaginal Inserts Due to Malfunctioning Applicator Plunger
FDA (Drugs) · 2019-01-16
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · defective delivery system
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29